WAGM-TV on MSN3d
Attorney General Aaron M. Frey Announces Settlement Agreement Will Bring $35 Insulin to Mainers
Attorney General Aaron M. Frey announced a settlement agreement with Sanofi-Aventis U.S. LLC after scrutiny over the ...
pharmaphorum10d
Novo hopes hypoglycaemia data will boost Tresiba
Novo Nordisk is applying for an expanded US label for its long-acting insulin Tresiba, hoping to gain an upper hand on Sanofi's older rival Lantus. Its data submitted to the FDA shows that ...
Maine announces settlement to reduce insulin costs
There is good news for Mainers who rely on insulin according to our media partners WMTW. Maine Attorney General Aaron Frey ...
pharmaphorum14d
FDA okays Viatris' insulin drug as first 'interchangeable' biosimilar
Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug, but only if specifically prescribed for a ...
Benzinga.com24d
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Merilog is available in a 3 mL prefilled pen and a 10 mL vial, joining two long-acting insulin biosimilars approved by the FDA in 2021. Merilog, a rapid-acting human insulin analog, is the first ...